India News

PIB’S BULLETIN ON COVID-19

Advertisement
PIB Headquarters

PIB’S BULLETIN ON COVID-19


Posted On:
28 JUL 2021 6:26PM by PIB Delhi

https://static.pib.gov.in/WriteReadData/userfiles/image/image0020FX3.png

https://static.pib.gov.in/WriteReadData/userfiles/image/image001BPSF.jpg

  • 44.61 Cr. Vaccine Doses administered so far under Nationwide Vaccination Drive
  • 3,06,63,147total recoveries across the country so far
  • Recovery Rate currently at 97.39%
  • 41,678patients recovered during last 24 hours
  • India reports 43,654new cases in last 24 hours
  • India’s Active caseload currently 3,99,436
  • Active cases constitute 1.27% of total cases
  • Weekly Positivity Rate remainsbelow5%, currently at 2.36%
  • Daily positivity rate at 2.51%, remains below 5%
  • Testing capacity substantially ramped up – 46.09 crore tests conducted(Total)

 

 

#Unite2FightCorona#IndiaFightsCorona

 

PRESS INFORMATION BUREAU

MINISTRY OF INFORMATION & BROADCASTING

GOVERNMENT OF INDIA

 

Image

Image

Image

COVID-19 Update

 

  • India’s Cumulative COVID-19 Vaccination Coverage exceeds 44.61 Cr
  • More than 40 Lakh vaccine doses administered in the last 24 hours
  • Recovery Rate stands at 97.39%
  • 43,654 Daily New Cases reported in last 24 hours
  • India’s Active Caseload (3,99,436) presently constitutes 1.27% of total cases
  • Daily Positivity Rate (2.51%) less than 5% for 51 consecutive days

 

India’s COVID-19 vaccination coverage exceeded 44.61 Cr yesterday.Cumulatively, 44,61,56,659 vaccine doses have been administered through 53,73,439 sessions, as per the provisional report till 8 am today. 40,02,358 vaccine doses were administered in the last 24 hours.These include:

 

HCWs

1st Dose

1,02,93,723

2nd Dose

77,53,002

FLWs

1st Dose

1,79,07,362

2nd Dose

1,10,20,080

Age Group 18-44 years

1st Dose

14,44,83,609

2nd Dose

68,86,188

Age Group 45-59 years

1st Dose

10,25,21,263

2nd Dose

3,62,42,655

Over 60 years

1st Dose

7,41,18,104

2nd Dose

3,49,30,673

Total

44,61,56,659

 

The new phase of universalization of COVID-19 vaccination has commenced from 21st June, 2021. The Union Government is committed to accelerating the pace and expanding the scope of COVID-19 vaccination throughout the country.

Out of the people infected since the beginning of the pandemic, 3,06,63,147people have already recovered from COVID-19 and 41,678 patients have recovered in the last 24 hours. This constitutes an overall recovery rate of 97.39%.

https://static.pib.gov.in/WriteReadData/userfiles/image/image0012026.jpg

 

India has reported 43,654daily new cases in the last 24 hours.

Less than 50,000 Daily New Cases have been reported since thirty-one continuous days. This is a result of sustained and collaborative efforts by the Centre and the States/UTs.

https://static.pib.gov.in/WriteReadData/userfiles/image/image002VZDW.jpg

India’s Active Caseload today stands at 3,99,436 and active cases now constitute1.27% of the country’s total Positive Cases.

https://static.pib.gov.in/WriteReadData/userfiles/image/image0039MVE.jpg

With substantially ramped up testing capacity across the country, a total of 17,36,857tests were conducted in the last 24 hours in the country. Cumulatively, India has conducted over 46 crore (46,09,00,978) tests so far.

While on one side testing capacity has been enhanced across the country, Weekly Positivity Rate is currently at 2.36% and the Daily Positivity rate stands at 2.51% today. Daily Positivity rate has remained below 5% for 51 consecutive days now.

Details: https://pib.gov.in/PressReleasePage.aspx?PRID=1739748

 

COVID-19 Vaccination Update

More than 46.23 Crore vaccine doses provided to States/UTs

More than 2.18 Crore balance and unutilized doses still available with States/UTs and private hospitals to be administered

 

As part of the nationwide vaccination drive, Government of India has been supporting the States and UTs by providing them COVID Vaccines free of cost. In the new phase of the universalization of the COVID19 vaccination drive, the Union Government will procure and supply (free of cost) 75% of the vaccines being produced by the vaccine manufacturers in the country to States and UTs.

 

VACCINE DOSES

(As on 28 July 2021)

SUPPLIED

46,23,27,530

IN PIPELINE

1,20,70,820

CONSUMPTION

44,29,95,780

BALANCE AVAILABLE

2,18,10,422

 

More than 46.23 crore (46,23,27,530) vaccine doses have been provided to States/UTs so far, through all sources and a further 1,20,70,820 doses are in the pipeline.Of this, the total consumption including wastages is 44,29,95,780 doses (as per data available at 8 AM today).

More than 2.18 Cr (2,18,10,422) balance and unutilized COVID Vaccine doses are still available with the States/UTs and private hospitals to be administered.

Details: https://pib.gov.in/PressReleasePage.aspx?PRID=1739750

Centre advises States to conduct State-specific Sero Surveys in consultation with ICMR to generate district-level data on sero-prevalence

The findings would guide formulation of localized Public Health Responses for COVID19 management

The Union Government has advised all States/UTs to conduct sero-prevalence surveys in consultation with ICMRto generate district-level data on sero-prevalence which is essential in formulating localized public health response measures. This has been stated in the letter written by the Union Health Secretary to Additional Chief Secretary/Principal Secretary/Secretary (Health) of all States.

The Union Health Ministry has referred to the findings of the 4th round of National Sero-Prevalence Survey done by ICMR and has advised the States to conduct the sero-prevalence studies in their ownStates/UTs in consultation with ICMR, so that such studies follow a standardized protocol, and the findings of such studies can then be utilized quickly by the respective State/UT to guide objective, transparent and evidence-based public health response to COVID-19.

https://static.pib.gov.in/WriteReadData/userfiles/image/image001SSL3.jpg

Details: https://pib.gov.in/PressReleasePage.aspx?PRID=1739902

Government taking steps to undertake the production of COVID BEEP on a large scale-Dr Jitendra Singh

COVID BEEP is India’s first indigenous, cost effective, wireless physiological parameters monitoring system for COVID-19 patients

 

Union Minister of State (Independent Charge) Science & Technology; Minister of State (Independent Charge) Earth Sciences; MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space, Dr Jitendra Singh said Government is taking steps to undertake the production of COVID BEEP on a large scale. In a statement laid on the table of the Loksabha in reply to a question, the Minister said that COVID BEEP is India’s first indigenous, cost effective, wireless physiological parameters monitoring system for COVID-19 patients, developed by ESIC Medical College Hyderabad in collaboration with Electronics Corporation of India Ltd. (ECIL) and Department of Atomic Energy.

Details: https://pib.gov.in/PressReleasePage.aspx?PRID=1739880

 

Important Tweets

 

*********

AS

(Release ID: 1740000)
Visitor Counter : 9

Source link

Show More
Advertisement

Related Articles

Back to top button